Glucocorticoid regulation of endothelial cell tight junction gene expression: novel treatments for diabetic retinopathy. - Wikidata - awgldk - TriplyDB

Glucocorticoid regulation of endothelial cell tight junction gene expression: novel treatments for diabetic retinopathy.

Glucocorticoid regulation of endothelial cell tight junction gene expression: novel treatments for diabetic retinopathy.

http://www.wikidata.org/entity/Q36311041

about

Updates on the Clinical Trials in Diabetic Macular Edema Fucoidan as a Potential Therapeutic for Major Blinding Diseases--A Hypothesis A review of therapies for diabetic macular oedema and rationale for combination therapy Vascular Pathophysiology in Hearing Disorders.Corticosteroid therapy for hearing and balance disorders The effect of a preoperative subconjuntival injection of dexamethasone on blood-retinal barrier breakdown following scleral buckling retinal detachment surgery: a prospective randomized placebo-controlled double blind clinical trial.Maternal glucocorticoid exposure alters tight junction protein expression in the brain of fetal sheep.Diabetic macular edema: new concepts in patho-physiology and treatment.Risk Factors for Refractory Diabetic Macular Oedema after Sub-Tenon's Capsule Triamcinolone Acetonide Injection.Correlative mRNA and protein expression of middle and inner ear inflammatory cytokines during mouse acute otitis media.Interleukin-1β and mitochondria damage, and the development of diabetic retinopathy.Effects of maternal treatment with corticosteroids on tight junction protein expression in the cerebral cortex of the ovine fetus with and without exposure to in utero brain ischemia.Therapeutic Options in Refractory Diabetic Macular Oedema.Clinical utility of intravitreal fluocinolone acetonide (Iluvien®) implant in the management of patients with chronic diabetic macular edema: a review of the current literature Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy.Progressive Depletion of Rough Endoplasmic Reticulum in Epithelial Cells of the Small Intestine in Monosodium Glutamate Mice Model of Obesity.Tight junctions and the modulation of barrier function in disease Current and future approaches in the prevention and treatment of diabetic retinopathy.Ontogeny and the effects of exogenous and endogenous glucocorticoids on tight junction protein expression in ovine cerebral cortices.Bone marrow-CNS connections: implications in the pathogenesis of diabetic retinopathy Altered transendothelial transport of hormones as a contributor to diabetes The effect of posterior sub-Tenon's capsule triamcinolone acetonide injection to that of pars plana vitrectomy for diabetic macular edema.Intravitreal triamcinolone acetonide inhibits breakdown of the blood-retinal barrier through differential regulation of VEGF-A and its receptors in early diabetic rat retinas.Intracellular delivery of dendrimer triamcinolone acetonide conjugates into microglial and human retinal pigment epithelial cells Dexamethasone Intravitreal Implant for Chronic Diabetic Macular Edema Resistant to Intravitreal Bevacizumab Treatment.Absence of diabetic retinopathy in a patient who has had diabetes mellitus for 69 years, and inadequate glycemic control: case presentation.Effects of sub-Tenon's capsule triamcinolone acetonide injection combined with microaneurysm photocoagulation on diabetic macular edema [Diabetic retinopathy risk factors].The role of ubiquitination and deubiquitination in the regulation of cell junctions.Intravitreal dexamethasone implants for diabetic macular edema.Impaired vascular endothelial function in patients with diabetic macular edema.Aflibercept in the treatment of diabetic macular edema: a review and consensus paper.Intravitreal dexamethasone implant versus anti-VEGF injection for treatment-naïve patients with retinal vein occlusion and macular edema: a 12-month follow-up study.Corticosteroids and Anti-Complement Therapy in Retinal Diseases.

P2860

Q26767100-E9A8D7C8-3473-4D97-A459-F7E19597C4F4 Q26768638-55178BEE-1A44-463D-B61B-30FB2CA080A3 Q27008325-F49D5EF4-3DB9-4A55-A616-C4979AFB48D1 Q30427799-E257FC5E-5FAC-457B-AD34-468B1A2CD5C4 Q30439597-4264904F-B8C1-4582-BB83-2645E54AD85F Q33534181-BA159506-46A7-4D8D-AA92-135E89D94E72 Q33589149-E079EEC7-3829-4D84-BFC9-D8C328324EA6 Q33713517-CAB6CC8B-2A6A-4FAA-B430-871F47BC3B10 Q35803183-5B69556B-6ECE-497F-820D-7903B3852246 Q35822607-FB528FB1-BF85-4573-BCFD-78B1EEA5F990 Q35928454-D7838B20-BC76-4BDF-B884-A5AF772E4BDC Q36072853-7E939F0C-DF44-4012-AB95-511EF773B3D0 Q36280656-4918921D-CC21-45D6-95E5-F4378F6E8290 Q36341458-DAC7B2B9-B99A-4BA5-BB44-996C8D253029 Q37084522-D5E28914-1AC1-46D0-B334-DE8AEA227879 Q37089093-429969BC-5F9A-4ED6-B84B-37C8E67914E3 Q37139446-5D191837-4EB2-417A-B199-868C0077370F Q37221516-B94344EC-25DF-4C15-B426-BC727925828C Q37442699-43E6091C-C78E-4DBA-B43F-DFF9D1BAF119 Q38011496-0D333AB2-57BC-4F17-91D7-5C71478157A1 Q38213715-5FC9E527-F37D-4EE9-B4C4-B19F7EBB0777 Q39248367-F2B62B9A-6171-4A2C-A873-534E17DC2DFB Q39545613-7BDC5089-35D7-42B8-8D14-F21FF4AF0915 Q41194130-B764EDAB-D8B6-497D-AF72-32166F3280FF Q41544958-8434A6A8-ACF9-44F2-B328-46455B2C21EC Q41785510-F27B6E55-207E-446E-949F-DE09CB688212 Q42039901-0E616EA7-0C70-49D0-9A34-9628E8E572E4 Q46573010-FBF1082C-A9A9-42CB-B116-17D53777A7E7 Q47592089-15982FA5-7FF0-4F07-91D8-15AFEE6C4B47 Q49241521-72E27059-A040-475F-AD1E-2DADCC81CBF2 Q49501949-CAD45212-2F8B-4D24-97EC-CD61073B2259 Q50095639-659098F8-5F2A-4DD7-9D83-FACFC78933E4 Q53619775-945F51E2-E12E-4751-B03A-6D0E554BEC92 Q54498160-DEAEE404-0348-43A4-A18B-84408A77AB45

P2860

Glucocorticoid regulation of endothelial cell tight junction gene expression: novel treatments for diabetic retinopathy.

http://www.wikidata.org/entity/Q36311041

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Glucocorticoid regulation of e ...... ents for diabetic retinopathy.

@ast

Glucocorticoid regulation of e ...... ents for diabetic retinopathy.

@en

type

label

Glucocorticoid regulation of e ...... ents for diabetic retinopathy.

@ast

Glucocorticoid regulation of e ...... ents for diabetic retinopathy.

@en

prefLabel

Glucocorticoid regulation of e ...... ents for diabetic retinopathy.

@ast

Glucocorticoid regulation of e ...... ents for diabetic retinopathy.

@en

P1433

Q36311041-6061E467-812D-48FA-887F-D6AE9F82C1A5

P1476

Q36311041-3DE7B1CE-3B95-4344-B68C-C4FAECC8BA84

P2093

Q36311041-8A438F9C-342D-4AE7-8A24-2F2C0F259C02

Q36311041-D9D965CC-6F43-4E18-9134-CE12F9177E8C

P2860

Q36311041-06C844CD-49C2-464A-875B-306DD9FCC18F

Q36311041-097D9D73-FA89-4379-BF5C-024521E50BEB

Q36311041-11EAB963-F0C4-4460-889A-A8FA8B1DBE07

Q36311041-164C3401-8F45-4184-A865-FB47E27C796A

Q36311041-18217489-E1D8-402F-9187-C10A96C25F3C

Q36311041-18A0889C-6DCD-4123-95FD-85531A72B242

Q36311041-1A99B0BB-3CD0-42EC-88EF-7244F61778F6

Q36311041-21CEDE75-75E8-4996-B46B-039F3D2D8C0C

Q36311041-21E455E9-696D-43CA-8C51-784886478F1F

Q36311041-30F36654-F2BE-4A6B-91E2-1A18D0A4DBC8

P304

Q36311041-C5350556-0C13-4DB2-A707-7C064FC7A084

P31

Q36311041-061A3F6B-0496-437C-AB88-8C5769A81F12

P356

Q36311041-9C9BBE0B-EA12-43B6-8C8B-D1443CEB5050

P433

Q36311041-4560D45B-A94F-490E-8D04-F35714AEA8D8

P478

Q36311041-E1FC6A5F-5BB8-4940-85C3-3BCABC8BFDEB

P577

Q36311041-F4B339BA-EA86-418B-8B8D-669C82161CB8

P698

Q36311041-403D19C2-99CA-45BC-8108-410E96A366B0

P921

Q36311041-E2C4E26E-2800-4398-9827-DCA5993513E6

P356

02713680500263598

P1433

Current Eye Research

P1476

Glucocorticoid regulation of e ...... ents for diabetic retinopathy.

@en

P2093

David A Antonetti

http://www.w3.org/2001/XMLSchema#string

Edward A Felinski

http://www.w3.org/2001/XMLSchema#string

P2860

Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor

Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats. Involvement of the glucocorticoid receptor and vascular permeability factor

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Protein interactions at the tight junction. Actin has multiple binding partners, and ZO-1 forms independent complexes with ZO-2 and ZO-3

Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice

Tight junction proteins

Heterogeneity in expression and subcellular localization of claudins 2, 3, 4, and 5 in the rat liver, pancreas, and gut

Steroid hormone receptors: many actors in search of a plot

Occludin binds to the SH3-hinge-GuK unit of zonula occludens protein 1: potential mechanism of tight junction regulation.

Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial.

P304

949-957

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/02713680500263598

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P577

2005-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16282129

http://www.w3.org/2001/XMLSchema#string

P921